Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Milestone Pharmaceuticals Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +1 vs. Q3 2023
- Shares held
- 17.8M
- −1.77M (−9.0%) vs. Q3 2023
- Total value
- $29.7M
- −$30.9M (−51.0%) vs. Q3 2023
- New holders
- 8
- 8 more added
- Sold out
- 7
- 11 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oliver Lagore Vanvalin Investment Group | 100 | $167 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 194 | $324 | 0.00% | 00.0% | Unchanged |
| ICA Group Wealth Management, LLC | 200 | $334 | 0.00% | +200 | New |
| Simplex Trading, LLC | 1,086 | $1.00K | 0.00% | +1,086 | New |
| National Bank of Canada | 3,850 | $6.85K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 6,100 | $10.2K | 0.00% | +4,000+190.5% | Added |
| Valeo Financial Advisors, LLC | 10,000 | $16.7K | 0.00% | −110,699−91.7% | Reduced |
| Federation des caisses Desjardins du Quebec | 10,500 | $17.5K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 10,662 | $17.8K | 0.00% | −233,694−95.6% | Reduced |
| Creative Planning | 13,080 | $21.8K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 13,135 | $21.9K | 0.00% | +13,135 | New |
| Susquehanna International Group, LLP | 13,299 | $22.2K | 0.00% | +13,299 | New |
| Advisor Group Holdings, Inc. | 14,054 | $23.5K | 0.00% | −3,239−18.7% | Reduced |
| Beta Wealth Group, Inc. | 14,127 | $23.6K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,576 | $29.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 18,686 | $31.0K | 0.00% | +18,686 | New |
| PVG Asset Management Corp | 19,320 | $32.3K | 0.16% | +3,915+25.4% | Added |
| BIT Capital GmbH | 20,000 | $33.4K | 0.00% | −187,276−90.4% | Reduced |
| Envestnet Asset Management Inc | 20,670 | $34.5K | 0.00% | +1,696+8.9% | Added |
| Group One Trading, L.P. | 20,762 | $34.7K | 0.00% | +20,762 | New |
| State Street Corp | 21,611 | $36.1K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 27,588 | $46.1K | 0.00% | 00.0% | Unchanged |
| Clear Creek Financial Management, LLC | 31,750 | $53.0K | 0.01% | +321+1.0% | Added |
| Northern Trust Corp | 31,970 | $53.4K | 0.00% | +31,970 | New |
| Ancora Advisors, LLC | 50,000 | $83.5K | 0.00% | +50,000 | New |
| Dimensional Fund Advisors LP | 73,704 | $123.2K | 0.00% | −13,135−15.1% | Reduced |
| Citadel Advisors LLC | 234,905 | $392.3K | 0.00% | −61,402−20.7% | Reduced |
| Barclays PLC | 255,185 | $426.2K | 0.00% | −390,305−60.5% | Reduced |
| Boxer Capital, LLC | 309,007 | $516.0K | 0.03% | 00.0% | Unchanged |
| BML Capital Management, LLC | 442,352 | $738.7K | 0.58% | +169,852+62.3% | Added |
| Ikarian Capital, LLC | 462,828 | $772.9K | 0.21% | 00.0% | Unchanged |
| Morgan Stanley | 689,400 | $1.15M | 0.00% | −11,216−1.6% | Reduced |
| VR Adviser, LLC | 925,048 | $1.54M | 0.11% | −1,283,764−58.1% | Reduced |
| Bleichroeder LP | 1,326,085 | $2.21M | 0.49% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,353,067 | $2.26M | 0.00% | −1,205,657−47.1% | Reduced |
| Millennium Management LLC | 1,494,489 | $2.50M | 0.00% | −200,802−11.8% | Reduced |
| Lion Point Capital, LP | 1,650,207 | $2.76M | 2.46% | +1,200,000+266.5% | Added |
| Alta Fundamental Advisers LLC | 1,671,289 | $2.79M | 1.49% | +495,100+42.1% | Added |
| RTW Investments, LP | 3,256,102 | $5.44M | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 3,270,749 | $5.46M | 0.00% | +490,009+17.6% | Added |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −335,068−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −113,187−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −48,796−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −41,109−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −38,495−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,955−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,693−100.0% | Sold out |